Skip to main content

Table 2 Characteristics of First-Ranked Loperamide Cases Reported to US Poison Centers by Reason for Exposure, National Poison Data System 2010–2022

From: Loperamide cases reported to United States poison centers, 2010–2022

Characteristics

Unintentional reasons

Intentional reasons

   

General

n (%)a

Therapeutic Error

n (%)a

Misuse

n (%)a

Otherf

n (%)a

Suspected Suicide

n (%)a

Misuse

n (%)a

Abuse

n (%)a

Unknown

n (%)a

Other

n (%)a

Unknown

n

Total

n (%)b

Sex

     

Male

3,111 (51.1)

891 (14.6)

139 (2.3)

6 (0.1)

436 (7.2)

497 (8.2)

676 (11.1)

91 (1.5)

246 (4.0)

57

6,150 (47.5)

Female

3,224 (48.0)

1,273 (19.0)

162 (2.4)

18 (0.3)

664 (9.9)

591 (8.8)

293 (4.4)

96 (1.4)

394 (5.9)

72

6,787 (52.5)

Unknown

25

5

0

1

6

4

3

3

 

3

50

Exposure type

      

Single-substance

5,796 (52.0)

2,043 (18.3)

279 (2.5)

21 (0.2)

581 (5.2)

965 (8.7)

762 (6.8)

149 (1.3)

544 (4.9)

108

11,248 (86.6)

Multiple-substance

564 (32.9)

126 (7.3)

22 (1.3)

4 (0.2)

525 (30.6)

127 (7.4)

210 (12.2)

41 (2.4)

96 (5.6)

24

1,739 (13.4)

Highest level of health care received

    

No HCF treatment received

4,342 (59.9)

1,845 (25.5)

195 (2.7)

8 (0.1)

6 (0.1)

351 (4.8)

46 (0.6)

29 (0.4)

424 (5.9)

22

7,268 (60.3)

Treated/ evaluated and released

1,344 (55.5)

159 (6.6)

45 (1.9)

4 (0.2)

276 (11.4)

278 (11.5)

221 (9.1)

30 (1.2)

63 (2.6)

15

2,435 (20.2)

Admitted to a HCF

205 (10.9)

44 (2.3)

21 (1.1)

11 (0.6)

687 (36.7)

236 (12.6)

551 (29.4)

87 (4.6)

32 (1.7)

60

1,934 (16.0)

 CCU

61 (6.5)

15 (1.6)

7 (0.7)

7 (0.7)

268 (28.4)

123 (13.0)

393 (41.6)

55 (5.8)

15 (1.6)

35

979 (8.1)

 Non-CCU

133 (22.7)

28 (4.8)

12 (2.1)

4 (0.7)

161 (27.5)

93 (15.9)

118 (20.2)

23 (3.9)

13 (2.2)

22

607 (5.0)

 Psychiatric facility

11 (3.2)

1 (0.3)

2 (0.6)

0 (0.0)

258 (74.8)

20 (5.8)

40 (11.6)

9 (2.6)

4 (1.2)

3

348 (2.9)

Patient refused referral/did not arrive at a HCF

173 (41.8)

41 (9.9)

13 (3.1)

2 (0.5)

41 (9.9)

63 (15.2)

38 (9.2)

15 (3.6)

28 (6.8)

9

423 (3.5)

Patient lost to follow-up/Left against medical advice/Unknown

296

80

27

0

96

164

116

29

93

26

927

Medical outcome

      

No effect

3,016 (73.6)

434 (10.6)

57 (1.4)

2 (0.0)

286 (7.0)

188 (4.6)

69 (1.7)

20 (0.5)

28 (0.7)

16

4,116 (34.4)

Minor effect

366 (26.5)

204 (14.8)

41 (3.0)

3 (0.2)

245 (17.7)

207 (15.0)

139 (10.1)

30 (2.2)

146 (10.6)

19

1,400 (11.7)

Serious medical outcomec

73 (4.7)

40 (2.6)

27 (1.7)

11 (0.7)

426 (27.5)

243 (15.7)

589 (38.0)

78 (5.0)

64 (4.1)

52

1,603 (13.4)

 Moderate effect

65 (6.3)

34 (3.3)

19 (1.8)

4 (0.4)

288 (27.7)

191 (18.4)

342 (32.9)

38 (3.7)

57 (5.5)

26

1,064 (8.9)

 Major effect

8 (1.7)

6 (1.3)

6 (1.3)

7 (1.5)

127 (27.7)

49 (10.7)

214 (46.7)

34 (7.4)

7 (1.5)

22

480 (4.0)

 Death

0 (0.0)

0 (0.0)

2 (3.6)

0 (0.0)

11 (20.0)

3 (5.5)

33 (60.0)

6 (10.9)

0 (0.0)

4

59 (0.5)

Not followedd

2,508 (51.8)

1,418 (29.3)

162 (3.3)

6 (0.1)

27 (0.6)

301 (6.2)

54 (1.1)

26 (0.5)

337 (7.0)

18

4,857 (40.6)

Unable to followe

397

73

14

3

122

153

121

36

65

27

1,011

Total (row %)

6,360 (49.5)

2,169 (16.9)

301 (2.3)

25 (0.2)

1,106 (8.6)

1,092 (8.5)

972 (7.6)

190 (1.5)

640 (5.0)

132

12,987 (100.0)

  1. CCU—Critical Care Unit, HCF—Health Care Facility
  2. aRow percentage may not add to 100.0% due to rounding error
  3. bColumn percentage may not add up to 100.0% due to rounding error
  4. cIncludes moderate effect, major effect, and death
  5. dNot followed (minimal clinical effects possible)
  6. eUnable to follow (judged as a potentially toxic exposure)
  7. fIncludes unintentional-environmental, unintentional-occupational, and unintentional-unknown